Today: 7 February 2026
Subscribe

Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus

Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus

NEW YORK, December 29, 2025, 10:30 PM ET — Market closed Shares of Stryker Corp (SYK) ended Monday down 0.5% at $352.50, giving back ground as Wall Street slipped in the final week of 2025. The late-day drift mattered more than usual for a stock that has a near-term calendar: a shareholder record date for the next dividend lands this week, and Stryker’s new president and chief operating officer is set to take the role on Jan. 1. With trading volumes typically lighter around year-end, modest risk-off moves can show up quickly in large-cap healthcare names, especially after a tech-heavy
30 December 2025
··
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

NEW YORK, December 29, 2025, 22:14 ET Novo Nordisk said it is lowering prices of its top-selling obesity drug Wegovy in China, after local outlet Yicai reported that list prices for the two highest doses were cut by 48% in the southwestern provinces of Yunnan and Sichuan. The new monthly list prices were 987 yuan ($141) and 1,284 yuan, Yicai said, citing local procurement authorities. Reuters The price move matters because China is fast becoming a pivotal growth market for weight-loss medicines, and pricing is now moving to the center of competition. Drugmakers are trying to lock in patients and
30 December 2025
·
Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

NEW YORK, December 29, 2025, 10:34 PM ET — Market closed Analog Devices Inc shares fell 0.44% to close at $275.63 on Monday, tracking a softer session for semiconductors and the broader U.S. market. Texas Instruments dropped 0.67% and NXP Semiconductors slid 1.08%, while the S&P 500 ended down 0.35%. MarketWatch The late-December drift matters because thin, year-end trading can magnify price moves even when company news is scarce. “In light volume trading, we’re seeing a reversal of what we saw over the last couple of days,” said Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. Reuters For
30 December 2025
···
Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

Lowe’s stock closes lower as Wall Street slips; housing data and Fed minutes in focus

NEW YORK, December 29, 2025, 10:26 PM ET — Market closed. Lowe’s Companies Inc shares finished Monday down 0.14% at $243.48. The stock was last indicated at $243.83 in after-hours trading. Yahoo Finance The move kept Lowe’s near a level investors have treated as a referendum on the U.S. housing cycle and interest-rate direction. Home-improvement spending can firm when mortgage rates ease and housing turnover rises, but it tends to stall when homeowners delay big projects. Housing data delivered a fresh data point late in the session. Contracts to buy existing homes — known as pending home sales, a gauge
30 December 2025
··
Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

NEW YORK, December 29, 2025, 10:27 PM ET — Market closed Boston Scientific shares closed down 0.3% at $95.76 on Monday. The stock traded between $95.53 and $96.64, with about 5.4 million shares changing hands. StockAnalysis The modest move still matters now because thin year-end liquidity can magnify small shifts in positioning. For large-cap healthcare names like Boston Scientific, traders are also watching whether defensive sectors can stay steady as leadership narrows in the final stretch of 2025. Wall Street’s main indexes finished lower, with the Dow down 0.51%, the S&P 500 off 0.35% and the Nasdaq down 0.50%, according
30 December 2025
··
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

NEW YORK, December 29, 2025, 22:17 ET — Market closed Gilead Sciences (GILD.O) shares were last up 0.15% at $124.91 on Monday, as investors weighed an analyst note that argued new Medicaid drug-pricing rules would have a limited financial impact on the company’s HIV franchise. Investing.com The call matters now because drugmakers and investors are still parsing a Trump administration pricing push that targets Medicaid and aims to bring U.S. medicine prices closer to those in other wealthy countries. Reuters For Gilead, the focus has been on whether “most-favored-nation” pricing — a policy that effectively ties prices to lower international
30 December 2025
·
Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

Danaher stock beats Wall Street dip as investors eye Fed minutes and Jan. 28 earnings

NEW YORK, December 29, 2025, 22:23 ET — Market closed Danaher Corp shares were last up about 0.1% at $230.63 on Monday, after trading between $229.26 and $231.77 during the session. The muted move still mattered for Danaher investors because the stock held up in a market that turned lower as the year winds down and liquidity thins, a setup that can amplify sector rotations. It also comes ahead of a key macro catalyst: the Federal Reserve’s December meeting minutes, due Tuesday, with traders pricing in additional rate cuts in 2026 as the U.S. dollar weakens into year-end. reuters.com U.S.
30 December 2025
···
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

NEW YORK, December 29, 2025, 22:14 ET — Market closed Amgen shares fell 1% on Monday, ending the session down $3.30 at $329.63. StockAnalysis The decline matters now because traders are heading into the final sessions of the year with U.S. indexes near record territory and liquidity thinner than usual. That backdrop can amplify moves in large-cap healthcare stocks even without a company-specific trigger. Reuters Wall Street’s main indexes closed lower, led by a retreat in heavyweight technology names, Reuters reported. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford
30 December 2025
···
BlackRock stock today: BLK barely higher as Wall Street slips; Fed minutes and data loom

BlackRock stock today: BLK barely higher as Wall Street slips; Fed minutes and data loom

NEW YORK, December 29, 2025, 22:07 ET — Market closed BlackRock Inc shares edged up on Monday, ending nearly flat at $1,088.40 as Wall Street turned lower in holiday-thinned trading. Reuters For BlackRock, modest moves in markets matter because they feed directly into assets under management (AUM) — the pool of client money it charges fees on. The firm oversees more than $13 trillion, Reuters has reported. Reuters That sensitivity is in sharper focus into year-end, as traders re-price the interest-rate outlook ahead of the Federal Reserve’s December meeting minutes due on Tuesday. Shifts in rate expectations can swing risk
30 December 2025
·
Qualcomm stock slips as chip sector cools; QCOM investors eye Feb. 4 earnings

Qualcomm stock slips as chip sector cools; QCOM investors eye Feb. 4 earnings

NEW YORK, December 29, 2025, 22:10 ET — Market closed QUALCOMM Incorporated (NASDAQ: QCOM) shares fell 0.8% to close at $173.43 on Monday, after trading between $175.19 and $172.79. StockAnalysis The move matters because chip stocks often magnify shifts in risk appetite, and investors have been quick to adjust exposure into the final sessions of the year. Qualcomm is closely tracked as a bellwether for high-end smartphones and related wireless demand. U.S. stocks ended lower on Monday, with the Nasdaq down 0.5% and the S&P 500 off 0.35%, while Treasury yields eased as investors recalibrated expectations for Federal Reserve rate
30 December 2025
···
Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

NEW YORK, December 29, 2025, 21:53 ET Lockheed Martin has offered to set up a C-130J Super Hercules final-assembly line in India as the Indian Air Force (IAF) moves toward buying up to 80 military transport aircraft, a PTI report carried by local media said. mint The pitch lands as India tries to modernise the air force’s transport fleet, a workhorse capability used to move troops, vehicles and relief supplies across long distances. It also underscores New Delhi’s push to tie major defence buys to local manufacturing, forcing overseas contractors to show how much work they will shift to India.
30 December 2025
·
Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

NEW YORK, December 29, 2025, 9:54 PM ET — Market closed Amphenol Corp shares fell 0.4% to end at $136.90 on Monday, as heavyweight technology names retreated and pulled the broader market lower in the final week of 2025. StockAnalysis+1 The move matters now because Amphenol sits at the intersection of industrial and tech spending: it sells connectors, sensors and high-speed cables used in data communications and other end markets that often trade with investor sentiment toward big tech and AI-linked hardware demand. Reuters With trading conditions typically thinner into year-end, swings tied to positioning can have an outsized impact
30 December 2025
·······
1 … 1,108 1,109 1,110 1,111 1,112 … 2,716

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop